19P Predictors of osimertinib response at second-line treatment in EGFR mutant non-small cell lung cancer patients with acquired T790M resistance mutation

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 32; p. S1351
Main Authors Dogan, I., Gürbüz, M., Paksoy, N., Khanmamadov, N., Vatansever, S., Saip, P., Demirkazik, A., Aydiner, A.
Format Journal Article
LanguageEnglish
Published 01.10.2021
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1016/j.annonc.2021.08.2015